Markets:

Overview

News

Currencies

International

Treasuries

GRAIL, Inc. - Common Stock (NQ:GRAL)

58.59 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Jun 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about GRAIL, Inc. - Common Stock

< Previous 1 2 3 4 Next >

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages GRAIL, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – GRAL

June 10, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

Securities Fraud Investigation Into Grail, Inc. (GRAL) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

June 10, 2026

From The Law Offices of Frank R. Cruz

Via Business Wire

GRAIL LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against GRAIL, Inc. and Encourages Investors to Contact the Firm

June 10, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

GRAL INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that GRAIL, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

June 10, 2026

From Robbins Geller Rudman & Dowd LLP

Via Business Wire

GRAIL INC (NASDAQ:GRAL) Stock Falls After-Hours Despite Q1 Beat and Galleri Test Volume Surge ↗

May 05, 2026

Via Chartmill

GRAIL, INC. (GRAL) INVESTOR ALERT Investors With Large Losses in GRAIL, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights

June 10, 2026

From Bernstein Liebhard LLP

Via GlobeNewswire

Berger Montague PC Investigating Claims on Behalf of GRAIL, Inc. (NASDAQ: GRAL) Investors After Class Action Filing

June 10, 2026

From Berger Montague

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in GRAIL, Inc. of Class Action Lawsuit and Upcoming Deadlines – GRAL

June 09, 2026

From Pomerantz LLP

Via GlobeNewswire

GRAL Investors Have Opportunity to Lead GRAIL, Inc. Securities Fraud Lawsuit with the Schall Law Firm

June 09, 2026

From The Schall Law Firm

Via Business Wire

Important Notice to Long-Term Shareholders of Badger Meter, Inc. (NYSE: BMI); GeneDx Holdings Corp. (NASDAQ: WGS); GRAIL, Inc. (NASDAQ: GRAL); and Verra Mobility Corporation (NASDAQ: VRRM): Grabar Law Office is Investigating Claims on Your Behalf

June 09, 2026

From Grabar Law Office

Via GlobeNewswire

Rosen Law Firm Urges GRAIL, Inc. (NASDAQ: GRAL) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

June 08, 2026

From The Rosen Law Firm, P.A.

Via Business Wire

Why Grail Could Be the Sleeper Stock Everyone's About to Notice ↗

June 08, 2026

Grail is on a quest to win in a $50 billion market.

Via The Motley Fool

SHAREHOLDER CLASS ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Grail (GRAL) Investors of Securities Class Action Deadline on August 4, 2026

June 07, 2026

From Faruqi & Faruqi, LLP

Via Business Wire

Investor Notice: Robbins LLP Informs Investors of the Grail, Inc. Class Action Lawsuit

June 05, 2026

From Robbins LLP

Via Business Wire

Here's Why Grail Stock Soared Higher in May (And Where the Company is Heading Now) ↗

June 05, 2026

Investors remain hopeful that the Galleri test can gain FDA approval and medical insurance coverage.

Via The Motley Fool

Topics Death

Why Grail Stock Popped Today ↗

June 04, 2026

The Galleri test failed its primary endpoint in a landmark trial, but that doesn't mean it doesn't have a big future.

Via The Motley Fool

Topics Death

Is Grail Stock a Bad-News Buy After Its Recent Pullback? ↗

June 04, 2026

The cancer test maker could still have a bright future.

Via The Motley Fool

Why Grail Shares Crashed Today ↗

June 01, 2026

The market was disappointed by the more detailed data on a landmark trial for the company's multi-cancer early detection (MCED) test.

Via The Motley Fool

Topics Death

GRAIL’s Galleri Test Cuts Stage 4 Cancer Diagnoses in Study Despite Missed Endpoint ↗

May 31, 2026

GRAIL (NASDAQ:GRAL) said new data presented at the American Society of Clinical Oncology annual meeting showed its Galleri multi-cancer early detection blood test can identify more cancers through...

Via MarketBeat

Grail's Slump Enters Week 10. Is There Any End in Sight? ↗

May 25, 2026

Despite a disappointing trial result, there's still a case for buying the stock, with a near-term catalyst on the horizon.

Via The Motley Fool

This Beaten-Down Growth Stock Could Soar 30%, According to Wall Street ↗

May 18, 2026

Grail's Galleri trial was disappointing, but it isn't down for the count yet.

Via The Motley Fool

GRAIL Says Galleri Demand Is Rising as NHS Talks, FDA Review Move Ahead ↗

May 17, 2026

GRAIL (NASDAQ:GRAL) said demand for its Galleri multi-cancer early detection test has continued to grow despite recent headlines related to its NHS study, according to comments made by Aaron, who...

Via MarketBeat

Here's Why Grail Shares Popped Higher This Week ↗

May 10, 2026

The company recently reported better-than-expected results, and investors are hoping for more positive news at the end of the month.

Via The Motley Fool

Grail (GRAL) Q1 2026 Earnings Transcript ↗

May 06, 2026

Grail (GRAL) Q1 2026 Earnings Transcript

Via The Motley Fool

Better Healthcare Stock to Own in a Recession: Defensive or Growth? ↗

April 04, 2026

The answer to the question might surprise many investors. It pays to be open-minded about risk.

Via The Motley Fool

Topics Economy Energy

GRAL Investors Have Opportunity to Join GRAIL, Inc. Fraud Investigation with the Schall Law Firm

April 03, 2026

From The Schall Law Firm

Via Business Wire

Here's Why Grail Stock Soared Higher This Week ↗

March 26, 2026

Wall Street continues to warm to the investment proposition for this high-risk and high-reward stock.

Via The Motley Fool

Topics Earnings

This Investor Exited a $22 Million GRAIL Stake Before a 50% One-Day Stock Crash Last Month ↗

March 22, 2026

GRAIL, Inc. develops blood-based cancer detection technologies for healthcare providers and individuals seeking early screening solutions.

Via The Motley Fool

Here's Why Grail Shares Crushed the Market This Week ↗

March 21, 2026

The company's stock received a favorable assessment from a Wall Street analyst this week.

Via The Motley Fool

Here's Why Grail Shares Crashed in February and Why it Could Be a Buying Opportunity ↗

March 11, 2026

The multi-cancer early detection (MCED) company delivered some extremely bad news to investors in February, but the stock may attract risk tolerant investors now.

Via The Motley Fool

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.